Results 151 to 160 of about 21,353 (254)

Medical Records-Based Postmarketing Safety Evaluation of Rare Events with Uncertain Status

, 2020
Hongyuan Cao, Lisa M. LaVange, Joseph F. Heyse, T. Christopher Mast, Michael R. Kosorok   +4 more
openalex   +1 more source

Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. [PDF]

, 1981
W.H.W. Inman
openalex   +1 more source

An Ethical Debate: Financial ties as part of informed consent to postmarketing research Attitudes of American doctors and patient

, 1995
J. La Puma, CB Stocking, W. D Rhoades, C. M Darling   +3 more
openalex   +2 more sources

Olestra Postmarketing Surveillance Study

, 1998
Alan R. Kristal, Ruth E. Patterson, MARIAN L NEUHOUSER, Mark Thornquist, Dianne Neumark‐Sztainer, Cheryl L. Rock, MARTHA C BERLIN, Lawrence J. Cheskin, Pamela J. Schreiner   +8 more
openalex   +1 more source

A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025. [PDF]

Transl Clin Pharmacol
Koo S, Kim CY, Lim JH, Lee E, Kim IY, Shin YG, Moon H.   +6 more
europepmc   +1 more source

Beyond the label: ethical and clinical implications of off-label drug use in pediatric emergency care. [PDF]

Ital J Pediatr
Colombo M, Plebani A, Agosti M.
europepmc   +1 more source

Concomitant use of psychotropics and donepezil in Japanese patients with dementia: Pooled postmarketing surveillance data analysis

, 2016
Kasumi Daidoji, Yukinori Sakata, Kenta Sumitomo, Mika Ishii, Tetsumi Toyoda, Mika Kawaguchi   +5 more
openalex   +1 more source

Risk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan. [PDF]

Int J Clin Oncol
Yuri A, Nakane S, Miyano Y, Yamada K, Sugano H, Nakatsuji E, Aoki M, Murayama A.   +7 more
europepmc   +1 more source

Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis [PDF]

, 2014
Xiang-qing Wang, Jiang Xiong, Wenhuan Xu, Shengyuan Yu, Xusheng Huang, Jiatang Zhang, Cheng-Lin Tian, Dehui Huang, Wei-quan Jia, Sen-yang Lang   +9 more
openalex   +1 more source

Evolving Real-World Data and Evidence Use for New Drugs and Regenerative Medical Products Approvals in Japan-An Analysis of the 6-Year Trend. [PDF]

Clin Pharmacol Ther
Okami S, Shimotsumagari K, Sadatsuki Y.
europepmc   +1 more source